Brief: Lbt Innovations Says US FDA Has Given 510(K) Clearance For Co's Culture Plate Reading Technology, Apas Independence With Associated Mrsa Analysis Module
29/10/2021 02:34
Oct 29 (Reuters) - LBT Innovations Ltd LBT.AX :
* US FDA HAS GIVEN 510(K) CLEARANCE FOR CO'S CULTURE PLATE
READING
TECHNOLOGY, APAS INDEPENDENCE WITH ASSOCIATED MRSA ANALYSIS
MODULE
Source text for Eikon: ID:nASXn299t
Further company coverage: LBT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clever Culture Systems
See all newsBrief: Clever Culture Systems Says Novo Nordisk Expand Use Of Apas Independence
Australia's Clever Culture Systems jumps nearly 29% on Novo Nordisk order
Australia's Clever Culture Systems falls after swinging to annual loss
Brief: Clever Culture Systems Says No Dividend Proposed For FY2026
Brief: Clever Culture Systems Ltd Says CSL Orders APAS Independence For Global QC Operations